MedPath

ZYCLARA

ZYCLARA

Approved
DIN Number

02392054

Drug Class

Human

Market Date

N/A

Company
HC

bausch health, canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02392054
AIG Number0135820003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D06BB10 IMIQUIMOD
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IMIQUIMODActive
Strength: 2.5 % / W/W
Monograph: IMIQUIMOD

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.